Biopharmaceutical Excipients Market by Product Type, by Application, by Geography – Forecast to 2028

Report - ID613084 | 12 July, 2019 | Healthcare | 100 pages | Report Type (Global) | Publisher Name - RFM

Market Analysis Insights 
The biopharmaceutical excipients market is expected to grow globally with an estimated CAGR of 6.5% to reach USD 3.33 billion by 2028. Growth of the pharmaceuticals market backed by functional excipients, surge in the generics market and increasing uptake of biopharmaceuticals are some of the main market drivers of this market. 

Market Segment
The Market is segmented based on Product
• Solubilizers & Surfactants/Emulsifiers
o Triglycerides
o Esters
• Polyols
o Mannitol
o Sorbitol
• Carohydrates
o Sucrose
o Dextrose
o Starch
• Specialty Biopharmaceutical Excipients/Others

The Market is segmented based on Functionality
• Fillers & Diluents
• Suspending & Viscosity Agents
• Coating Agents
• Binders
• Flavoring Agents & Sweeteners
• Disintegrants
• Colorants
• Lubricants & Glidants
• Preservatives
• Emulsifying Agents 

The Market is segmented based on Formulation
• Tablet
• Capsule
o Hard Gelatin Capsules
o Soft Gelatin Capsules
• Topical
• Parenteral

The above segmentation is covered for all countries and regions listed below
• North and South America
o U.S.
o Canada
o Mexico
o Brazil
o Rest of Americas
• Europe
o Germany
o France
o U.K.
o Italy 
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o Rest of APAC
• Middle East and Africa
Vendor Landscape Competitive Research
The major players in biopharmaceutical excipients market are DuPont de Nemours, Inc., Roquette Frères¸ Ashland, BASF AG,  Kerry Inc., Evonik Industries, Croda International Plc, Associated British Foods plc, Archer Daniels Midland CompanY, The Lubrizol Corporation, Innophos Holdings, Wacker Chemie AG
Leave a Message